title: AHA statement highlights gender differences in PCI: part II.
authors.affiliation: Pulmonary and Critical Care Medicine, Mount Sinai Medical Center New York, NY, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: White
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000592:standards*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000628:therapy; D019317:Evidence-Based Medicine; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012737:Sex Factors; D016387:Women's Health
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors